Circadian Clock Dysregulation and Prostate Cancer: A Molecular and Clinical Overview-Reference-Cited by-同舟云学术

Circadian Clock Dysregulation and Prostate Cancer: A Molecular and Clinical Overview

Published:2023-01 Issue: Volume:17 Page:
ISSN:1179-5549
Container-title:Clinical Medicine Insights: Oncology
language:en
Short-container-title:Clin Med Insights Oncol

Author:

Kaakour Dalia¹^ORCID,Fortin Bridget²,Masri Selma²,Rezazadeh Arash¹

Affiliation:

1. Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Orange, CA, USA

2. Department of Biological Chemistry, University of California, Irvine, Irvine, CA, USA

Abstract

Circadian clock dysregulation has been implicated in various types of cancer and represents an area of growing research. However, the role of the circadian clock in prostate cancer has been relatively unexplored. This literature review will highlight the potential role of circadian clock dysregulation in prostate cancer by examining molecular, epidemiologic, and clinical data. The influence of melatonin, light, night shift work, chronotherapy, and androgen independence are discussed as they relate to the existing literature on their role in prostate cancer.

Publisher

SAGE Publications

Subject

Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/11795549231211521

Reference112 articles.

1. National Cancer Institute. Cancer stat facts: common cancer sites. https://seer.cancer.gov/statfacts/html/common.html. Published 2022. Accessed October 20, 2022.

2. Key statistics for prostate cancer. https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics.html.

3. Transcriptional architecture of the mammalian circadian clock

4. Crystal Structure of the Heterodimeric CLOCK:BMAL1 Transcriptional Activator Complex

5. Posttranslational Mechanisms Regulate the Mammalian Circadian Clock

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circadian clock disruption and growth of kidney cysts in autosomal dominant polycystic kidney disease;2024-08-05

2. The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer;Journal of Experimental & Clinical Cancer Research;2024-06-20

3. The pharmacoepigenetic paradigm in cancer treatment;Frontiers in Pharmacology;2024-04-24